bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.02.20.706960

The T cell receptor repertoire captures healthy aging and CMV independently from epigenetic clocks

Abstract

Human aging is the process through which numerous biological changes occur during life, affecting various processes. In some elderly individuals, this functional decline becomes more pronounced, leading to frailty, a condition characterised by reduced physiological reserves and increased vulnerability to stress. With the global rise of life expectancy, identification of biomarkers for healthspan and frailty are becoming more important. In this study, we directly compare two molecular readouts, namely the T cell receptor (TCR) repertoire and epigenetic clocks, on their ability to discern healthy aging. On blood samples from sixteen individuals, across age-matched healthy elderly and frail individuals, both TCR sequencing and epigenetic profiling were performed. A significantly higher TCR repertoire diversity in the CD4+ T cells differentiated the healthy elderly individuals from the frailty ones. Epigenetic clock signatures of biological relative to chronological ageing rate, did not show a clear difference between both groups. However, when taking into account the CMV-serostatus, a significant increase in epigenetic aging could be observed in the CMV-seropositive individuals. Our results support a clear hypothesis on the role of CMV infection in the healthy aging of the immune system. In healthy elderly, CMV is typically controlled by CD4+ T cells, however, in the frail elderly, the burden of managing the infection shifts to the CD8+ T cells. This change is marked by two key changes: a decrease in TCR diversity for seropositive individuals compared to seronegative individuals, as well as an increase in the fraction of CMV-associated TCRs within the CD8+ T cells. These findings contribute to our understanding of aging and provide insight into how CMV-infection may affect healthy aging and frailty. They also underline the crucial role of the immune system in healthy aging and the value of further investigating ageing-related health/disease patterns in the TCR repertoire to determine healthspan/lifespan.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Breëns, M., De Man, K., Heylen, Y., Ha, M. K., Kuznetsova, M., Besbassi, H., Affaticati, F., Berghe, W. V., Ogunjimi, B., Meysman, P.. 2026-02-22. The T cell receptor repertoire captures healthy aging and CMV independently from epigenetic clocks. https://doi.org/10.64898/2026.02.20.706960

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Common viral infections seed regionally distinct resident memory T cells in the human CNS

T cells persist in the central nervous system (CNS) and can drive both protection and neurological disease. How these cells are organized in humans and what they recognize is largely unknown. Here, we profiled CD8 T cells across anatomically distinct CNS regions, obtained through on-site autopsies and temporal lobe resection surgeries, using single-cell RNA sequencing, paired T cell receptor sequencing, and DNA-barcoded tetramers. Resident memory T cells (TRM) specific for Epstein-Barr virus, cytomegalovirus, influenza A, and SARS-CoV-2 were identified across CNS compartments. Anatomical location was the strongest correlate of TRM cell state, with leptomeningeal cells adopting a cytokine-poised TRM program, whereas brain TRM cells were transcriptionally restrained. Cells of the same clonotype spanned tissues yet adopted local transcriptional states. Viral specificity added another layer of TRM heterogeneity with GZMK/GZMA-expressing EBV-specific populations and interferon-stimulated gene signatures in SARS-CoV-2 and Influenza A-specific cells. The human CNS thus harbors regionally distinct CD8+ TRM shaped by common viral exposures.

immunology↗

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Rheumatic diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA) and osteoarthritis (OA), show distinct phenotypes yet respond to overlapping therapies, implicating shared immune mechanisms. In the Transimmunom cohort, we profiled peripheral blood from 240 individuals (47 healthy, 44 OA, 91 RA, 58 SpA) across deep immunophenotyping, immunoproteomics and Treg-Teff transcriptomics. Single-layer analyses revealed broader Treg than Teff remodeling, along with a shared pattern of reduced activated Tregs and expanded Helios+ Tregs across all diseases, alongside a decrease in functional Treg subpopulations, including CTLA4+ and CD45RA- Tregs. In RA specifically, LAG3+ Tregs were also expanded. Combining omics layers outperformed single-layer approaches for disease classification. Among individual layers, Treg transcriptomes were most discriminative, and integration uncovered disease-specific programs. Unsupervised clustering identified a cross-disease cluster independent of activity, treatment and age, mapping to early disease (<= years) and dominated by a Treg dysfunction-associated program. These results provide a biological rationale for the therapeutic "window of opportunity" concept and duration-stratified Treg-directed trials.

immunology↗

Inhibitory Fc Receptor sets a time limit on macrophage response to IgG

Antibodies engage both activating Fc Receptors and the inhibitory receptor Fc{gamma}RIIB. Why macrophages need a dedicated inhibitory receptor rather than simply tuning activating receptor signaling is unclear. Using DNA-based chimeric receptors and in silico modeling, we independently controlled activating and inhibitory Fc Receptors. We found that Fc{gamma}RIIB imposed a time limit on macrophage phagocytosis and ERK signaling. The time limit is due to activating Fc Receptors converting PI(4,5)P2 to PI(3,4,5)P3, which is subsequently converted to PI(3,4)P2 by Fc{gamma}RIIB. This leads to a pulse of active signaling, which is sufficient for phagocytosis of small bacteria-sized targets but not phagocytosis of large targets and TNF secretion. Unlike engaging Fc{gamma}RIIB, reducing activating Fc Receptor signaling decreased initiation of phagocytosis, the speed of PI(3,4,5)P3 generation, and the amplitude of ERK signaling. Our results demonstrate that Fc{gamma}RIIB controls the duration of IgG signaling, while the activating Fc Receptors control sensitivity.

immunology↗